These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1741053)

  • 21. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
    Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of simian immunodeficiency virus for vaccine research.
    Daniel MD; Sehgal PK; Kodama T; Wyand MS; Ringler DJ; King NW; Schmidt DK; Troup CD; Desrosiers RC
    J Med Primatol; 1990; 19(3-4):395-9. PubMed ID: 2231691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys.
    Murphey-Corb M; Montelaro RC; Miller MA; West M; Martin LN; Davison-Fairburn B; Ohkawa S; Baskin GB; Zhang JY; Miller GB
    AIDS; 1991 Jun; 5(6):655-62. PubMed ID: 1883540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Robinson HL; Lu S; Mustafa F; Johnson E; Santoro JC; Arthos J; Winsink J; Mullins JI; Montefiori D; Yasutomi Y
    Ann N Y Acad Sci; 1995 Nov; 772():209-11. PubMed ID: 8546394
    [No Abstract]   [Full Text] [Related]  

  • 29. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells.
    Goldstein S; Elkins WR; London WT; Hahn A; Goeken R; Martin JE; Hirsch VM
    J Med Primatol; 1994; 23(2-3):75-82. PubMed ID: 7966237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
    Hirsch VM; Goldstein S; Hynes NA; Elkins WR; London WT; Zack PM; Montefiori D; Johnson PR
    J Infect Dis; 1994 Jul; 170(1):51-9. PubMed ID: 8014520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monkey business over AIDS vaccine.
    Weiss R
    BMJ; 1991 Oct; 303(6807):872. PubMed ID: 1933002
    [No Abstract]   [Full Text] [Related]  

  • 35. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.
    O'Connor D; Friedrich T; Hughes A; Allen TM; Watkins D
    Immunol Rev; 2001 Oct; 183():115-26. PubMed ID: 11782252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of studying T cell responses in SIV-infected rhesus macaques.
    Valentine LE; Watkins DI
    Trends Microbiol; 2008 Dec; 16(12):605-11. PubMed ID: 18964016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
    Gabriel B; Fiebig U; Hohn O; Plesker R; Coulibaly C; Cichutek K; Mühlebach MD; Bannert N; Kurth R; Norley S
    Virology; 2016 Feb; 489():1-11. PubMed ID: 26685794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses.
    Dittmer U; Bodemer W; Hunsmann G; Voss G
    Immunol Today; 1994 Feb; 15(2):90-1. PubMed ID: 8155269
    [No Abstract]   [Full Text] [Related]  

  • 39. Timing of retroviral infection influences anamnestic immune response in vaccinated primates.
    Anderson DE; Singapuri A; Kang KH; Montefiori DC; Torres JV
    Viral Immunol; 2005; 18(4):689-94. PubMed ID: 16359235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.
    Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.